Dave Muoio
Housed on a biochip, the startup's technology can deliver results from a single drop of blood within 15 minutes.
Also: Funding announcements for Think Research, Kinetic and Aura.
The company said its new investment will fuel commercialization of its Pivot program, which consists of an app, a connected carbon monoxide breathalyzer and other resources.
CEO Robbie Cape said the investment will be used to meet demand, build new capabilities and ensure high-quality care.
The collective entity offers its vertically-integrated service to patients in Northern California, and is eyeing platform partnerships elsewhere in the country.
The startup's seed funding comes from Lux Capital, former Twitter heads and others.
The smartphone-connected device includes a microphone and ECG leads, and relies on machine learning capabilities to identify irregular heart rhythms.
Also: Lark Health names new chief medical officer; Medidata's new board member
The collaboration hopes to develop battery-free wearables that could help inform personalized skin disease treatments.
The company's devices, which are available with or without a connected component, look to avoid inconvenient IV drug delivery.